Inogen (INGN) Net Margin Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -883.00 |
| Dec 31, 2025 | -307.00 |
| Sep 30, 2025 | -344.00 |
| Jun 30, 2025 | -843.00 |
| Mar 31, 2025 | -559.00 |
| Dec 31, 2024 | -255.00 |
| Sep 30, 2024 | -1,419.00 |
| Jun 30, 2024 | -1,635.00 |
| Mar 31, 2024 | -2,456.00 |
| Dec 31, 2023 | -4,693.00 |
| Sep 30, 2023 | -7,169.00 |
| Jun 30, 2023 | -2,677.00 |
| Mar 31, 2023 | -4,181.00 |
| Dec 31, 2022 | 3,252.00 |
| Sep 30, 2022 | -1,965.00 |
| Jun 30, 2022 | -1,633.00 |
| Mar 31, 2022 | -2,898.00 |
| Dec 31, 2021 | -3,134.00 |
| Sep 30, 2021 | 539.00 |
| Jun 30, 2021 | -808.00 |
| Mar 31, 2021 | -681.00 |
| Dec 31, 2020 | -1,646.00 |
| Sep 30, 2020 | -890.00 |
| Jun 30, 2020 | -392.00 |
| Mar 31, 2020 | -657.00 |
| Dec 31, 2019 | -696.00 |
| Sep 30, 2019 | 22.00 |
| Jun 30, 2019 | 253.00 |
| Mar 31, 2019 | 630.00 |
| Dec 31, 2018 | -9,957.00 |
| Sep 30, 2018 | 2,269.00 |
| Jun 30, 2018 | 617.00 |
| Mar 31, 2018 | 897.00 |